Home > Financial Ratios > SENORES PHARMACEUTICALS

SENORES PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
SENORES PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SENORES PHARMACEUTICALS
Please provide your vote to see the results

SENORES PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 97.67145.46171.43577.75-

What is the latest Core EBITDA Growth ratio of SENORES PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of SENORES PHARMACEUTICALS is 97.67 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar202697.67
Mar2025145.46
Mar2024171.43
Mar2023577.75
Mar2022-

How is Core EBITDA Growth of SENORES PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2026 97.67
-32.85
Mar2025 145.46
-15.15
Mar2024 171.43
-70.33
Mar2023 577.75
0
Mar2022 0 -

Other Financial Ratios of SENORES PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of SENORES PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SENORES PHARMACEUTICALS ₹6,218.9 Cr -0.5% -7.2% 98.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹434,280.0 Cr -2.4% -6.2% 11.8% Stock Analytics
DIVIS LABORATORIES ₹246,737.0 Cr -3.3% 1.4% 57.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,129.0 Cr -4.5% -4% 35.9% Stock Analytics
CIPLA ₹108,808.0 Cr -3.6% -5% -10.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,170.0 Cr -0.2% 2.5% -3% Stock Analytics


SENORES PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SENORES PHARMACEUTICALS

-0.5%

-7.2%

98.4%

SENSEX

-2.3%

-6.6%

-12%


You may also like the below Video Courses